Home
Orbimed Advisors reported a 5% stake in C4 Therapeutics CCCC · 3,568,346 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 5%
- Last report
- 6.6% · filed 25/05/15
- Shares held
- 3,568,346 sh
- Class
- Common Stock, par value $0.0001 per share
- Stock
- C4 Therapeutics CCCC
- Holder
- Orbimed Advisors
- Event date
- 25/09/30
- Filed
- 25/11/14
5% stake · −1.6pp from the last report
- Stake
- 5%
- Last report
- 6.6%
- Since last report
- −1.6pp
C4 Therapeutics trades, last 26 weeks
What else happened in C4 Therapeutics around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Orbimed Advisors's other 5% stake reports
- Orbimed Advisors
5% stakeElectra Therapeutics
5% stakeElectra Therapeutics
ETRA
11% stake
6,885,170 sh
11% stake
Filed 09/25
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
13.5% stake
12,175,159 sh
13.5% stake
Filed 09/10
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
17.2% stake
12,175,159 sh
17.2% stake
Filed 08/18
- Orbimed Advisors
5% stakeBlossomHill Therapeutics
5% stakeBlossomHill Therapeutics
BLSM
8.9% stake
2,714,279 sh
8.9% stake
Filed 08/18
- Orbimed Advisors
5% stakeWhitehawk Therapeutics
5% stakeWhitehawk Therapeutics
WHWK
7.3% stake
3,934,296 sh
7.3% stake
Filed 08/14
